Abhijit Joshi achievements and Milestones

1. ABHIJIT JOSHI
Achievements and Milestones

2. ABHIJIT JOSHI

3.  Veritas Legal has been founded by Abhijit Joshi, a professional with 22 years of experience
in the Indian legal industry and a winner of many national and international accolades.
 He was the senior partner and chief executive officer (CEO) at AZB & Partners until
November 2104.
 His key practice areas included mergers and acquisitions, general corporate and commercial
law and private client law.
 Mr Abhijit Joshi started his journey with merely 15 lawyers at AZB which has now grown
into an organization that has over 200 lawyers.
 He is an advocate, solicitor and solicitor England and Wales having completing his articles
under Amarchand Mangaldas managing partner Cyril Shroff in the early nineties.
Introduction

4. Achievements and Milestones -
 Abhijit Joshi has featured in International Who’s Who Legal as ‘Leading Lawyer for Mergers &
Acquisitions 2013’ and ‘Prominent Lawyer in the Franchise Sector’.
 He has also been listed by IFLR1000 as ‘Leading Lawyer for Mergers & Acquisitions Leading
and Private Equity 2012 & 2013’.
 Abhijit is associated with Entrepreneurs Organization, Young Presidents’ organisation and is a
member of Legal Practice Division of International Bar Association.
 A member of the Law Firm Management Committee of the International Bar Association,
Abhijit is also associated with Law Society of England and Wales.
 He holds a Bachelor of Law degree from Bombay University.

5. Achievements and Milestones -
 He has been involved in some of the major landmark deals, such as the Rs 5,150 crore Tech
Mahindra - Satyam Computer Services merger, Usd 2.6 billion Tata -Docomo transaction
among many others
 Swedish firm Recipharm has picked up 74 per cent stake in sterile injectables maker Nitin
Lifesciences for Rs. 671 crore ($103 million) in an all cash deal.
 Veritas Legal acted for Recipharm with a team led by Partner Nandish Vyas along with
Associates Natasha Sethna and Tejasvi Saxena.
 This is the largest inbound deal in the sterile injectables space in the last two years, after the
$1.75 billion acquisition of Strides Arcolab’s subsidiary Agila Specialities by Mylan in 2013.

6. THANK YOU !!!